Literature DB >> 15667567

Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin.

Joanne Mohan1, Moira E Bruce, Neil A Mabbott.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are a group of subacute infectious neurodegenerative diseases that are characterized by the accumulation in affected tissues of PrP(Sc), an abnormal isoform of the host prion protein (PrPc). Following peripheral exposure, TSE infectivity and PrP(Sc) usually accumulate in lymphoid tissues prior to neuroinvasion. Studies in mice have shown that exposure through scarified skin is an effective means of TSE transmission. Following inoculation via the skin, a functional immune system is critical for the transmission of TSEs to the brain, but until now, it has not been known which components of the immune system are required for efficient neuroinvasion. Temporary dedifferentiation of follicular dendritic cells (FDCs) by treatment with an inhibitor of the lymphotoxin-beta receptor signalling pathway (LTbetaR-Ig) 3 days before or 14 days after inoculation via the skin, blocked the early accumulation of PrP(Sc) and TSE infectivity within the draining lymph node. Furthermore, in the temporary absence of FDCs before inoculation, disease susceptibility was reduced and survival time significantly extended. Treatment with LTbetaR-Ig 14 days after TSE inoculation also significantly extended the disease incubation period. However, treatment 42 days after inoculation did not affect disease susceptibility or survival time, suggesting that the infection may have already have spread to the nervous system. Together these data show that FDCs are essential for the accumulation of PrP(Sc) and infectivity within lymphoid tissues and subsequent neuroinvasion following TSE exposure via the skin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15667567      PMCID: PMC1782078          DOI: 10.1111/j.1365-2567.2004.02074.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  57 in total

1.  Rapid prion neuroinvasion following tongue infection.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion.

Authors:  Marco Prinz; Mathias Heikenwalder; Tobias Junt; Petra Schwarz; Markus Glatzel; Frank L Heppner; Yang-Xin Fu; Martin Lipp; Adriano Aguzzi
Journal:  Nature       Date:  2003-10-15       Impact factor: 49.962

Review 3.  Follicular dendritic cells as targets for intervention in transmissible spongiform encephalopathies.

Authors:  Neil A Mabbott; Moira E Bruce
Journal:  Semin Immunol       Date:  2002-08       Impact factor: 11.130

4.  A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.

Authors:  Jennifer L Gommerman; Keith Giza; Stuart Perper; Irene Sizing; Apinya Ngam-Ek; Cheryl Nickerson-Nutter; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Transmission of scrapie by steel-surface-bound prions.

Authors:  E Flechsig; I Hegyi; M Enari; P Schwarz; J Collinge; C Weissmann
Journal:  Mol Med       Date:  2001-10       Impact factor: 6.354

Review 6.  Prions in dermatology.

Authors:  Omar Lupi
Journal:  J Am Acad Dermatol       Date:  2002-05       Impact factor: 11.527

7.  Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie.

Authors:  P Aucouturier; F Geissmann; D Damotte; G P Saborio; H C Meeker; R Kascsak; R Kascsak; R I Carp; T Wisniewski
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

8.  The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.

Authors:  Philip R Taylor; Matthew C Pickering; Marie H Kosco-Vilbois; Mark J Walport; Marina Botto; Siamon Gordon; Luisa Martinez-Pomares
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

9.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Authors:  C A Llewelyn; P E Hewitt; R S G Knight; K Amar; S Cousens; J Mackenzie; R G Will
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

10.  Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility.

Authors:  Neil A Mabbott; Janice Young; Irene McConnell; Moira E Bruce
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  14 in total

1.  Interaction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure.

Authors:  Gauthier Dorban; Valérie Defaweux; Caroline Demonceau; Sylvain Flandroy; Pierre-Bernard Van Lerberghe; Nandini Falisse-Poirrier; Joëlle Piret; Ernst Heinen; Nadine Antoine
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

2.  Pathogenesis of chronic wasting disease in cervidized transgenic mice.

Authors:  Davis M Seelig; Gary L Mason; Glenn C Telling; Edward A Hoover
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 3.  Tunnelling nanotubes: a highway for prion spreading?

Authors:  Karine Gousset; Chiara Zurzolo
Journal:  Prion       Date:  2009-04-01       Impact factor: 3.931

4.  Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Authors:  Yael Friedman-Levi; Haim Ovadia; Romana Hoftberger; Ofira Einstein; Oded Abramsky; Herbert Budka; Ruth Gabizon
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  B cell-specific S1PR1 deficiency blocks prion dissemination between secondary lymphoid organs.

Authors:  Simon W F Mok; Richard L Proia; Volker Brinkmann; Neil A Mabbott
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

6.  Skin-derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure.

Authors:  Joanne Mohan; John Hopkins; Neil A Mabbott
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

7.  Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Authors:  Yael Friedman-Levi; Romana Hoftberger; Herbert Budka; Tehila Mayer-Sonnenfeld; Oded Abramsky; Haim Ovadia; Ruth Gabizon
Journal:  J Neuroinflammation       Date:  2012-03-21       Impact factor: 8.322

8.  Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen.

Authors:  Laura McCulloch; Karen L Brown; Barry M Bradford; John Hopkins; Mick Bailey; Klaus Rajewsky; Jean C Manson; Neil A Mabbott
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

Review 9.  The diverse roles of mononuclear phagocytes in prion disease pathogenesis.

Authors:  Gwennaelle J Wathne; Neil A Mabbott
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

10.  The efficacy of tetracyclines in peripheral and intracerebral prion infection.

Authors:  Ada De Luigi; Laura Colombo; Luisa Diomede; Raffaella Capobianco; Michela Mangieri; Claudia Miccolo; Lucia Limido; Gianluigi Forloni; Fabrizio Tagliavini; Mario Salmona
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.